HDAC9 and early-onset autosomal dominant Alzheimer disease: In the last few years, HDAC inhibitors have been extensively tested for different types of cancer therapy [117,118,119] and as cognitive enhancers [120], which may potentially help neurodegenerative diseases such as Alzheimer’s disease [121].